APA – Kigali (Rwanda) – European Commission President Ursula von der Leyen is expected to arrive in Rwanda on Monday for a one-day working visit where she will meet with senior officials during the discussions that will focus on various bilateral and multilateral issues, aan authoritative source confirmed to APA Thursday in Kigali
During the visit, Ursula will also pay tribute to genocide victims at the Kigali Genocide Memorial, the final resting place for more than 250,000 victims of the Genocide against the Tutsi which she is expected to tour on Monday.
According to the programme, the EU Commission president, flanked with high-level dignitaries including official government representatives will also participate at the inauguration of BioNTech, a next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases.
The manufacturing plant for mRNA-based vaccines is located at the Kigali Special Economic Zone located at Masoro, a suburb of kigali city in a section earmarked for biopharma manufacturing.
The Rwandan facility, covering the size of about 30,000 square metres, will be equipped Monday with one of the two BioNTainers for the production of mRNA.
The second container for the production of the formulated bulk drug producction is expected to commence approximately by the end of 2024.
The Company exploits a wide array of computational discovery and therapeutic drug platforms for the rapid development of novel biopharmaceuticals.
Its broad portfolio of oncology product candidates includes individualized and off-the-shelf mRNA-based therapies, innovative chimeric antigen receptor (CAR) T cells, several protein-based therapeutics, including bispecific immune checkpoint modulators, targeted cancer antibodies and antibody-drug conjugate (ADC) therapeutics, as well as small molecules.
The company expects to set up additional factories of the like in Senegal and South Africa.
CU/abj/APA